Table of Contents 1 Market Overview 1.1 Hemophilia Treatment Introduction 1.2 Market Analysis by Type 1.2.1 On-demand 1.2.2 prophylaxis 1.3 Market Analysis by Applications 1.3.1 Replacement therapy 1.3.2 ITI therapy 1.3.3 Gene therapy 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 CSL Behring 2.1.1 Business Overview 2.1.2 Hemophilia Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 CSL Behring Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Baxalta 2.2.1 Business Overview 2.2.2 Hemophilia Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Baxalta Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Pfizer Inc 2.3.1 Business Overview 2.3.2 Hemophilia Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Pfizer Inc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 BioMarin 2.4.1 Business Overview 2.4.2 Hemophilia Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 BioMarin Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Bayer Healthcare 2.5.1 Business Overview 2.5.2 Hemophilia Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Bayer Healthcare Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Biogen 2.6.1 Business Overview 2.6.2 Hemophilia Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Biogen Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Novo Nordisk 2.7.1 Business Overview 2.7.2 Hemophilia Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Novo Nordisk Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Roche 2.8.1 Business Overview 2.8.2 Hemophilia Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Roche Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Shire Plc 2.9.1 Business Overview 2.9.2 Hemophilia Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Shire Plc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Hemophilia Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Hemophilia Treatment Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Hemophilia Treatment Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Hemophilia Treatment Manufacturer Market Share in 2017 3.3.2 Top 6 Hemophilia Treatment Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Hemophilia Treatment Market Analysis by Regions 4.1 Global Hemophilia Treatment Sales, Revenue and Market Share by Regions 4.1.1 Global Hemophilia Treatment Sales and Market Share by Regions (2013-2018) 4.1.2 Global Hemophilia Treatment Revenue and Market Share by Regions (2013-2018) 4.2 North America Hemophilia Treatment Sales and Growth Rate (2013-2018) 4.3 Europe Hemophilia Treatment Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Hemophilia Treatment Sales and Growth Rate (2013-2018) 4.5 South America Hemophilia Treatment Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Hemophilia Treatment Sales and Growth Rate (2013-2018) 5 North America Hemophilia Treatment by Countries 5.1 North America Hemophilia Treatment Sales, Revenue and Market Share by Countries 5.1.1 North America Hemophilia Treatment Sales and Market Share by Countries (2013-2018) 5.1.2 North America Hemophilia Treatment Revenue and Market Share by Countries (2013-2018) 5.2 United States Hemophilia Treatment Sales and Growth Rate (2013-2018) 5.3 Canada Hemophilia Treatment Sales and Growth Rate (2013-2018) 5.4 Mexico Hemophilia Treatment Sales and Growth Rate (2013-2018) 6 Europe Hemophilia Treatment by Countries 6.1 Europe Hemophilia Treatment Sales, Revenue and Market Share by Countries 6.1.1 Europe Hemophilia Treatment Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Hemophilia Treatment Revenue and Market Share by Countries (2013-2018) 6.2 Germany Hemophilia Treatment Sales and Growth Rate (2013-2018) 6.3 UK Hemophilia Treatment Sales and Growth Rate (2013-2018) 6.4 France Hemophilia Treatment Sales and Growth Rate (2013-2018) 6.5 Russia Hemophilia Treatment Sales and Growth Rate (2013-2018) 6.6 Italy Hemophilia Treatment Sales and Growth Rate (2013-2018) 7 Asia-Pacific Hemophilia Treatment by Countries 7.1 Asia-Pacific Hemophilia Treatment Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Hemophilia Treatment Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Hemophilia Treatment Revenue and Market Share by Countries (2013-2018) 7.2 China Hemophilia Treatment Sales and Growth Rate (2013-2018) 7.3 Japan Hemophilia Treatment Sales and Growth Rate (2013-2018) 7.4 Korea Hemophilia Treatment Sales and Growth Rate (2013-2018) 7.5 India Hemophilia Treatment Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Hemophilia Treatment Sales and Growth Rate (2013-2018) 8 South America Hemophilia Treatment by Countries 8.1 South America Hemophilia Treatment Sales, Revenue and Market Share by Countries 8.1.1 South America Hemophilia Treatment Sales and Market Share by Countries (2013-2018) 8.1.2 South America Hemophilia Treatment Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Hemophilia Treatment Sales and Growth Rate (2013-2018) 8.3 Argentina Hemophilia Treatment Sales and Growth Rate (2013-2018) 8.4 Colombia Hemophilia Treatment Sales and Growth Rate (2013-2018) 9 Middle East and Africa Hemophilia Treatment by Countries 9.1 Middle East and Africa Hemophilia Treatment Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Hemophilia Treatment Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Hemophilia Treatment Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Hemophilia Treatment Sales and Growth Rate (2013-2018) 9.3 UAE Hemophilia Treatment Sales and Growth Rate (2013-2018) 9.4 Egypt Hemophilia Treatment Sales and Growth Rate (2013-2018) 9.5 Nigeria Hemophilia Treatment Sales and Growth Rate (2013-2018) 9.6 South Africa Hemophilia Treatment Sales and Growth Rate (2013-2018) 10 Global Hemophilia Treatment Market Segment by Type 10.1 Global Hemophilia Treatment Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Hemophilia Treatment Sales and Market Share by Type (2013-2018) 10.1.2 Global Hemophilia Treatment Revenue and Market Share by Type (2013-2018) 10.2 On-demand Sales Growth and Price 10.2.1 Global On-demand Sales Growth (2013-2018) 10.2.2 Global On-demand Price (2013-2018) 10.3 prophylaxis Sales Growth and Price 10.3.1 Global prophylaxis Sales Growth (2013-2018) 10.3.2 Global prophylaxis Price (2013-2018) 11 Global Hemophilia Treatment Market Segment by Application 11.1 Global Hemophilia Treatment Sales Market Share by Application (2013-2018) 11.2 Replacement therapy Sales Growth (2013-2018) 11.3 ITI therapy Sales Growth (2013-2018) 11.4 Gene therapy Sales Growth (2013-2018) 12 Hemophilia Treatment Market Forecast (2018-2023) 12.1 Global Hemophilia Treatment Sales, Revenue and Growth Rate (2018-2023) 12.2 Hemophilia Treatment Market Forecast by Regions (2018-2023) 12.2.1 North America Hemophilia Treatment Market Forecast (2018-2023) 12.2.2 Europe Hemophilia Treatment Market Forecast (2018-2023) 12.2.3 Asia-Pacific Hemophilia Treatment Market Forecast (2018-2023) 12.2.4 South America Hemophilia Treatment Market Forecast (2018-2023) 12.2.5 Middle East and Africa Hemophilia Treatment Market Forecast (2018-2023) 12.3 Hemophilia Treatment Market Forecast by Type (2018-2023) 12.3.1 Global Hemophilia Treatment Sales Forecast by Type (2018-2023) 12.3.2 Global Hemophilia Treatment Market Share Forecast by Type (2018-2023) 12.4 Hemophilia Treatment Market Forecast by Application (2018-2023) 12.4.1 Global Hemophilia Treatment Sales Forecast by Application (2018-2023) 12.4.2 Global Hemophilia Treatment Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Hemophilia Treatment Picture Table Product Specifications of Hemophilia Treatment Figure Global Sales Market Share of Hemophilia Treatment by Types in 2017 Table Hemophilia Treatment Types for Major Manufacturers Figure On-demand Picture Figure prophylaxis Picture Figure Hemophilia Treatment Sales Market Share by Applications in 2017 Figure Replacement therapy Picture Figure ITI therapy Picture Figure Gene therapy Picture Figure United States Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Canada Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Germany Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure France Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure UK Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Russia Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Italy Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure China Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Japan Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Korea Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure India Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Hemophilia Treatment Revenue (Value) and Growth Rate (2013-2023) Table CSL Behring Basic Information, Manufacturing Base and Competitors Table CSL Behring Hemophilia Treatment Type and Applications Table CSL Behring Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Baxalta Basic Information, Manufacturing Base and Competitors Table Baxalta Hemophilia Treatment Type and Applications Table Baxalta Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Inc Basic Information, Manufacturing Base and Competitors Table Pfizer Inc Hemophilia Treatment Type and Applications Table Pfizer Inc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BioMarin Basic Information, Manufacturing Base and Competitors Table BioMarin Hemophilia Treatment Type and Applications Table BioMarin Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer Healthcare Basic Information, Manufacturing Base and Competitors Table Bayer Healthcare Hemophilia Treatment Type and Applications Table Bayer Healthcare Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biogen Basic Information, Manufacturing Base and Competitors Table Biogen Hemophilia Treatment Type and Applications Table Biogen Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Hemophilia Treatment Type and Applications Table Novo Nordisk Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Hemophilia Treatment Type and Applications Table Roche Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shire Plc Basic Information, Manufacturing Base and Competitors Table Shire Plc Hemophilia Treatment Type and Applications Table Shire Plc Hemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Hemophilia Treatment Sales by Manufacturer (2016-2017) Figure Global Hemophilia Treatment Sales Market Share by Manufacturer in 2016 Figure Global Hemophilia Treatment Sales Market Share by Manufacturer in 2017 Table Global Hemophilia Treatment Revenue by Manufacturer (2016-2017) Figure Global Hemophilia Treatment Revenue Market Share by Manufacturer in 2016 Figure Global Hemophilia Treatment Revenue Market Share by Manufacturer in 2017 Figure Top 3 Hemophilia Treatment Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Hemophilia Treatment Manufacturer (Revenue) Market Share in 2017 Figure Global Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Global Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table Global Hemophilia Treatment Sales by Regions (2013-2018) Table Global Hemophilia Treatment Sales Market Share by Regions (2013-2018) Table Global Hemophilia Treatment Revenue by Regions (2013-2018) Figure Global Hemophilia Treatment Revenue Market Share by Regions in 2013 Figure Global Hemophilia Treatment Revenue Market Share by Regions in 2017 Figure North America Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Europe Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Asia-Pacific Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure South America Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Middle East and Africa Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure North America Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table North America Hemophilia Treatment Sales by Countries (2013-2018) Table North America Hemophilia Treatment Sales Market Share by Countries (2013-2018) Figure North America Hemophilia Treatment Sales Market Share by Countries in 2013 Figure North America Hemophilia Treatment Sales Market Share by Countries in 2017 Table North America Hemophilia Treatment Revenue by Countries (2013-2018) Table North America Hemophilia Treatment Revenue Market Share by Countries (2013-2018) Figure North America Hemophilia Treatment Revenue Market Share by Countries in 2013 Figure North America Hemophilia Treatment Revenue Market Share by Countries in 2017 Figure United States Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Canada Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Mexico Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Europe Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table Europe Hemophilia Treatment Sales by Countries (2013-2018) Table Europe Hemophilia Treatment Sales Market Share by Countries (2013-2018) Table Europe Hemophilia Treatment Revenue by Countries (2013-2018) Figure Europe Hemophilia Treatment Revenue Market Share by Countries in 2016 Figure Europe Hemophilia Treatment Revenue Market Share by Countries in 2017 Figure Germany Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure UK Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure France Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Russia Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Italy Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Asia-Pacific Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Hemophilia Treatment Sales by Countries (2013-2018) Table Asia-Pacific Hemophilia Treatment Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Hemophilia Treatment Sales Market Share by Countries 2017 Table Asia-Pacific Hemophilia Treatment Revenue by Countries (2013-2018) Figure Asia-Pacific Hemophilia Treatment Revenue Market Share by Countries 2017 Figure China Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Japan Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Korea Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure India Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Southeast Asia Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure South America Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table South America Hemophilia Treatment Sales by Countries (2013-2018) Table South America Hemophilia Treatment Sales Market Share by Countries (2013-2018) Figure South America Hemophilia Treatment Sales Market Share by Countries in 2017 Table South America Hemophilia Treatment Revenue by Countries (2013-2018) Table South America Hemophilia Treatment Revenue Market Share by Countries (2013-2018) Figure South America Hemophilia Treatment Revenue Market Share by Countries in 2017 Figure Brazil Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Argentina Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Colombia Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Middle East and Africa Hemophilia Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Hemophilia Treatment Sales by Countries (2013-2018) Table Middle East and Africa Hemophilia Treatment Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Hemophilia Treatment Sales Market Share by Countries in 2017 Table Middle East and Africa Hemophilia Treatment Revenue by Countries (2013-2018) Table Middle East and Africa Hemophilia Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Hemophilia Treatment Revenue Market Share by Countries in 2013 Figure Middle East and Africa Hemophilia Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure UAE Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Egypt Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure Nigeria Hemophilia Treatment Sales and Growth Rate (2013-2018) Figure South Africa Hemophilia Treatment Sales and Growth Rate (2013-2018) Table Global Hemophilia Treatment Sales by Type (2013-2018) Table Global Hemophilia Treatment Sales Share by Type (2013-2018) Table Global Hemophilia Treatment Revenue by Type (2013-2018) Table Global Hemophilia Treatment Revenue Share by Type (2013-2018) Figure Global On-demand Sales Growth (2013-2018) Figure Global On-demand Price (2013-2018) Figure Global prophylaxis Sales Growth (2013-2018) Figure Global prophylaxis Price (2013-2018) Table Global Hemophilia Treatment Sales by Application (2013-2018) Table Global Hemophilia Treatment Sales Share by Application (2013-2018) Figure Global ITI therapy Sales Growth (2013-2018) Figure Global Gene therapy Sales Growth (2013-2018) Figure Global Hemophilia Treatment Sales, Revenue and Growth Rate (2018-2023) Table Global Hemophilia Treatment Sales Forecast by Regions (2018-2023) Table Global Hemophilia Treatment Market Share Forecast by Regions (2018-2023) Figure North America Sales Hemophilia Treatment Market Forecast (2018-2023) Figure Europe Sales Hemophilia Treatment Market Forecast (2018-2023) Figure Asia-Pacific Sales Hemophilia Treatment Market Forecast (2018-2023) Figure South America Sales Hemophilia Treatment Market Forecast (2018-2023) Figure Middle East and Africa Sales Hemophilia Treatment Market Forecast (2018-2023) Table Global Hemophilia Treatment Sales Forecast by Type (2018-2023) Table Global Hemophilia Treatment Market Share Forecast by Type (2018-2023) Table Global Hemophilia Treatment Sales Forecast by Application (2018-2023) Table Global Hemophilia Treatment Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

CSL Behring Baxalta Pfizer Inc BioMarin Bayer Healthcare Biogen Novo Nordisk Roche Shire Plc